John C. Flickinger
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
Papers in
- Oncology 11
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 3
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 3
- Co-authors
- Adam E. Snook (13 shared papers)Ulrich Rodeck (1 shared paper)Robert D. Carlson (4 shared papers)Scott A. Waldman (9 shared papers)Trevor R. Baybutt (6 shared papers)Tara S. Abraham (3 shared papers)Michael S. Magee (1 shared paper)Priyanka Prajapati (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Regenerative Medicine (1 paper)Frontiers in Immunology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesIndiaFrance
In The Last Decade
John C. Flickinger
17 papers receiving 507 citations
Peers
Comparison fields: 5 of 64
- Biotechnology 114
- Immunology 247
- Oncology 257
- Genetics 71
- Neurology 20
Countries citing papers authored by John C. Flickinger
This map shows the geographic impact of John C. Flickinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Flickinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Flickinger more than expected).
Fields of papers citing papers by John C. Flickinger
This network shows the impact of papers produced by John C. Flickinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Flickinger. The network helps show where John C. Flickinger may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Flickinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 115 | |
| 2 | 2017 | 90 | |
| 3 | 2018 | 90 | |
| 4 | 2020 | 66 | |
| 5 | 2019 | 50 | |
| 6 | 2020 | 27 | |
| 7 | 2018 | 18 | |
| 8 | 2019 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2019 | 6 | |
| 13 | 2021 | 3 | |
| 14 | 2015 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2012 | 1 |
About John C. Flickinger
John C. Flickinger is a scholar working on Oncology, Immunology, Biotechnology, Molecular Biology and Genetics, having authored 17 papers that have together received 516 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Cancer Research and Treatments (4 papers), Immunotherapy and Immune Responses (3 papers), Virus-based gene therapy research (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Brain Metastases and Treatment (2 papers) and Listeria monocytogenes in Food Safety (2 papers). The work is most often cited by research in Biotechnology (114 citations), Immunology (247 citations), Oncology (257 citations), Genetics (71 citations) and Neurology (20 citations). John C. Flickinger has collaborated with scholars based in United States, India and France. Frequent co-authors include Adam E. Snook, Ulrich Rodeck, Robert D. Carlson, Scott A. Waldman, Trevor R. Baybutt, Tara S. Abraham, Michael S. Magee, Priyanka Prajapati, Adam R. Hersperger and Glen P. Marszalowicz. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, International Journal of Radiation Oncology*Biology*Physics, Regenerative Medicine, Frontiers in Immunology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.